REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search

CAR T-Cell Therapy for Leukemia

Newsweek-and-JCI-Small

Sheba Medical Center provides CAR T-cell therapy for leukemia, an advanced form of immunotherapy for both adults and children.

This treatment involves modifying a patient’s own T-cells to recognize and target cancer cells. Sheba offers access to CAR-T therapies, including programs with point-of-care manufacturing capabilities, allowing some treatments to be produced locally.

*Important: Patients accepted into Sheba’s point-of-care CAR-T program benefit from in-house cell manufacturing at Sheba. However, pediatric patients with leukemia are currently only eligible for commercially available CAR-T therapies.

CAR-T THERAPY leukemia

How Does The Therapy Work for Leukemia?

CAR T treatment for leukemia is an innovative process that uses your own immune cells to seek and destroy cancerous cells.

An amount of blood is taken from the patient and the T-cells, a type of immune cell, are separated out from the rest of the blood in a special laboratory. The T-cells are then genetically engineered to cause them to produce chimeric antigen receptors (CARs). The CARs will allow the T-cells to recognize tumor cells, targeting and destroying the tumor.

After some blood is taken from the patient, the T-cells, a type of immune cell, are removed from the sample. Using advanced genetic engineering techniques, the T-cells are modified, causing them to create chimeric antigen receptors (CARs). These CARs program the T-cells to find and destroy cancer cells when injected back into the patient.

The patient receives chemotherapy while the modified T-cells grow in our laboratory. The chemotherapy dampens the patient’s immune system, permitting the CAR T-cells to do a better job of eliminating malignant cells.

What are the Possible Side Effects from CAR T-Cell Therapy?

CAR T-cells are associated with significant but reversible side effects in 40-60% of patients treated.

These include a flu-like syndrome with fever and shortness of breath. This syndrome may lead to low blood pressure, chills, and more. Neurologic side effects, like a headache and seizures, have been reported. All these effects are reversible, but may be significant and require treatment in the ICU.

Who is a Candidate for CAR T-Cell Therapy for Leukemia?

The therapy is only provided to patients who have undergone at least two previous leukemia treatments.

Sheba and other medical centers located in the US are continually striving to improve these success rates through constant advanced research.

Sheba is excited to announce that it now offers the innovative CAR T-cell therapy for patients with Multiple Myeloma and is the first medical center in the world to pioneer its application for Acute Myelogenous Leukemia (AML) with 8:21 translocation and CD19 expression as part of a clinical study.

We also offer a full diagnostic procedure to determine whether this treatment is a suitable option for a patient.

Related Doctors

Arnon Nagler

Arnon Nagler, M.D., M.Sc., served for many years as a direct

Prof. Amos Toren

Prof. Amos Toren is the former Director of the Pediatric Hem

Abraham Avigdor

Dr. Abraham Avigdor is the director of the Institute of Hema

Dr. Michal Yalon, pediatric hemato-oncology specialist at Sheba Medical Center
Michal Yalon

Dr. Michal Yalon specializes in Pediatric-Hemato-Oncology at

Dr. Elad Jacoby, pediatric hemato-oncologist specializing in CAR T-cell therapy at Sheba Medical Center
Prof. Elad Jacoby

Prof. Jacoby, the Head of Sheba’s Pediatric Cell Therapy C

Request a consultation

Sheba Medical Center provides innovative, personalized medical care to patients from around the world. We are the largest, most comprehensive hospital in the Middle East and dedicated to providing advanced and compassionate medicine for everyone.

We welcome all cases, including the rarest and the most challenging. Our medical teams collaborate to provide the best possible health outcomes. From your initial inquiry through the long-term follow-up care, we are here for you.

Request a consultation and a Sheba Case Manager will contact you shortly: